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First report of Klebsiella pneumonia carbapenemase-
producing Pseudomonas aeruginosa isolated from burn
patients in Iran: phenotypic and genotypic methods
Erster Bericht über Klebsiella pneumoniae Carbapenemase-bildende
Pseudomonas aeruginosa-Stämme, isoliert von Verbrennungspatienten
im Iran: phenotypische und genotypische Methoden
Abstract
Wound infection associated with carbapenem-resistant Pseudomonas
aeruginosa in burn patients is a growing problem. One of the main
Abdolaziz Rastegar
Lari1,2
mechanisms of resistance to carbapenem antibiotics is the ability of
Leila Azimi1,2P. aeruginosa to produce carbapenemase enzymes. Klebsiella pneumo-
Mohammad Rahbar3nia carbapemenase (KPC) is an important type of carbapenemasewhich
can hydrolyze carbapenem antibiotics. The Modified Hodge Test (MHT) Reza Alaghehbandan4
and boronic acid as a KPC inhibitor are two phenotypic methods used
Mahboobeh
Sattarzadeh-Tabrizi5
for detection of carbapenemase. The sensitivity and specificity of these
two phenotypic tests for the identification of KPC can be measured by
PCR.
In this study, 241 P. aeruginosa strains were isolated from wounds of
hospitalized burn patients. Carbapenem-resistant P. aeruginosa isolates
1 Department of Microbiology
and Razi Drug Research
were determined by the disk diffusion method. KPC-producing car- Center, Iran University of
bapenem-resistant strains were examined using the Modified Hodge Medical Sciences, Tehran,
IranTest, followed by boronic acid. Further, strains with positive responses
to MHT and boronic acid tests were analyzed with the PCR molecular 2 Department of Microbiology,
Tehran University of Medical
Sciences, Tehran, Iran
method. One hundred eighty-six of 241 isolates were resistant to car-
bapenems and 75 were positive in the MHT. Three exhibited an at least
5-mm diameter difference when meropenem was combined with
3 Department of Microbiology,
Iranian Reference Healthboronic acid vs meropenem alone in the boronic acid test. Two strains
had a specific band with primer No.1 after gel electrophoresis. Laboratory, Ministry of Health
This study showed that MHT, despite excellent sensitivity, has variable
specificity independent of bacterial species. Further, the use of KPC
and Medical Education,
Tehran, Iran
inhibitors such as boronic acid did not yield favorable sensitivity and
4 Department of Pathology and
Immunology, Washingtonspecificity among the specimens from Iranian patients. Thus, it seems
that sequencing after PCR should be considered the gold standard for
the detection of KPC-producing P. aeruginosa.
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blaKPC 5 Motahhari Burn Hospital,
Tehran University of Medical
Sciences, Tehran, IranZusammenfassung
Wundinfektionen bei Verbrennungspatientenmit Carbapenem-resisten-
tem Pseudomonas (P.) aeruginosa sind ein wachsendes Problem. Einer
der hauptsächlichen Resistenzmechanismen gegen Carbapeneme ist
die Fähigkeit von P. aeruginosa, Carbapenemase-Enzyme zu bilden.
Klebsiella pneumonia Carbapenemase (KPC) ist eine wichtige Carbape-
nemase, die Carbapeneme hydrolysieren kann. Der modifizierte Hodge-
test (MHT) und Boronsäure als KPC-Inhibitor sind zwei phenotypische
Methoden zur Detektion der Carbapenemase. Die Sensitivität und
Spezifität beider Tests zur KPC-Identifikation kannmittels PCR bestimmt
werden.
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In der Studie wurden 241 P. aeruginosa-Stämme von Wunden hospita-
lisierter Verbrennungspatienten isoliert. Carbapenem-resistente P. ae-
ruginosa-Isolate wurdenmittels Plättchendiffusionstest bestimmt. KPC-
bildende Carbapenem-resistente Stämmewurdenmittelsmodifiziertem
Hodgetest (MHT) und anschließendmit Boronsäure detektiert. Stämme
mit positiver Reaktion wurden mittels PCR analysiert.
168 Isolate waren resistent gegen Carbapenemeund 75waren imMHT
positiv. Drei Isolate exhibierten mindestens 5-mm Durchmesser als
Differenz, wenn Meropenem mit Boronsäure kombiniert wurde vs Me-
ropenemallein imBoronsäuretest. Zwei Stämmehatten eine spezifische
Bande mit Primer Nr. 1 in der Gelelektrophorese.
Die Studie zeigt, dass derMHT neben seiner hohen Sensitivität abhängig
von der Bakterienspecies eine unterschiedliche Spezifität aufweist.
Ferner erhöht der Einsatz eines KPC-Inhibitors wie Boronsäure nicht
die Sensitivität und Spezifität bei den isolierten Stämmen. Daher scheint
die Sequenzierungmittels PCR der Goldstandard für die Detektion KPC-
bildender P. aeruginosa-Stämme zu sein.
Schlüsselwörter: P. aeruginosa, KPC, Boronsäure, modifizierter
Hodge-Test, blaKPC
Background
Resistance to carbapenems such as broad spectrum
betalactamantibiotics in Pseudomonas aeruginosa is an
increasing challenge wordwide [1], [2], [3]. A growing in-
cidence of carbapenem-resistant P. aeruginosa is associ-
ated with KPC production, especially in burn patients,
and is an important concern in health-care systems [1].
The importance of this resistance is due to the potential
for resistance to all betalactam antibiotics in KPC-produc-
ing microorganisms, which is one of the main choices for
treatment of wound infection [4], [5], [6], [7]. KPC-produ-
cing bacteria are emerging in various countries and re-
gions, such as Greece, Iran and Latin America [4], [8],
[9]. Rapid and accurate detection of KPC-producing bac-
teria is necessary for preventing the spread of the kpc
gene, given that it is located in transferable genetic ele-
ments (i.e. plasmids and transposons) [4], [5], [10]. Ac-
cording to CLSI (Clinical and Laboratory Standards Insti-
tute), MHT is one of the phenotypic methods of KPC
confirmation ([11], Supplemental Table 2A-S2); however,
some studies suggest that MHT may not have a high
specificity for the identification of KPC and may only
confirm carbapebemaseenzymesbut not carbapenemase
types. Nevertheless, most researchers believe that MHT
has a high sensitivity rate [12].
The use of boronic acid – a KPC inhibitor – is another
phenotypic method for confirming KPC. Moreover, PCR
for the kpc gene is utilized for molecular detection of this
enzyme. The aim of this study was to evaluate these two
phenotypic methods (MHT and boronic acid) for the de-
tection of KPC by PCR as a molecular test.
Materials and methods
Bacterial strains
In this study, 241 Pseudomonas spp. were isolated from
hospitalized burn patients in Motahari Hospital in Tehran,
Iran. The species of bacteria were determined by specific
biochemical tests such as oxidase, TSI, and gelatinase.
PCR was used to confirm identification of Pseudomonas
aeruginosa strains using specific primers for oprI for
bacteria genus and oprL for species [13]. Pseudomonas
aeruginosa ATCC 27853 and Acinetobacter baumannii
ATCC 19606 were used as the positive and negative
controls, respectively.
Antibiotic susceptibility testing was conducted against
carbapenems (Imipenem, Meropenem and Ertapenem)
using the disk diffusion method according to the CLSI
recommendation. ThemodifiedHodge test was performed
for carbapenem-resistant strains.
Modified Hodge Test
According to CLSI, MHT is one of the confirmatory tests
for phenotypic identification of the KPC enzyme. In this
study, MHT was performed according to the CLSI recom-
mendation by using E. coli ATCC 25922. K. pneumoniae
ATCC BAA-1705 – MHT-positive was used as a positive
control.
Use of KPC inhibitor
Using 400 µg 3-amino phenyl boronic acid (APBA) as a
KPC inhibitor, per disk plus Meropenem vs Meropenem
alone is another phenotypic method for confirming iden-
tification of KPC. Strains with an increase of at least 5mm
aroundMeropenemplus APBA vsMeropenemalonewere
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Table 1: Five different primer sequences used in this study
Figure 1: PCR amplification fragments for detection of the kpc gene among Pseudomonas aeruginosa isolates
M: 1kb DNA size marker; lane 1–3 and 5–7: punctuation here is confusing negative strains; lane 4: negative control; lane 8 and
10: positive strains.
considered KPC-producing strains. On the other hand,
the synergistic effect of Meropenem plus Oxacillin
(750 µg/disc) was used to eliminate false positive re-
sponses.
PCR of the kpc gene
PCR was used to confirm the kpc gene in MHT-positive
P. aeruginosa with 5 different specific primers (Table 1,
Figure 1). PCR program was performed as follows. Initial
denaturation for each of the genes was performed at
95°C for 5min and thereafter 30 cycles with denaturation
at 95°C for 1min. The annealing temperatures consisted
of blaKPC 64°C, blaKPCA 56°C, blaKPCB 56°C, blaKPCc
60°C and blaKPCD55°C , the annealing timewas 1min.
The extension time was 1 min at 72°C. The final exten-
sion for all genes was done at 72°C for 5 min.
Results
In this study, 241 strains were identified and confirmed
as P. aeruginosa. One hundred eighty-six strains were
resistant to all tested carbapenems (Imipenem,
Meropenem and Ertapenem). Seventy-five strains had
MHT-positive test results. A synergism effect between
Meropenem and APBA was observed in 11 P. aeruginosa
strains with positive MHT test results. On the other hand,
only 3 strains had synergism with APBA alone and the
remaining 8 strains had synergism with Oxacillin simul-
taneously. Further, PCR with different specific primers
showed specific bands after gel electrophoresis in only
twoMHT-positive strains with primer No. 1. The proportion
of positive results frommolecular testing of carbapenem-
resistant P. aeruginosa is 0.01 (1.07%). One of two strains
had a synergistic effect with APBA.
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Discussion
Resistance to carbapenems in P. aeruginosa is a growing
problem worldwide [1], [2], [3]. Resistance to car-
bapenems associated with KPC production is an alarming
problem for health care systems [1], because the kpc
gene can transfer between P. aeruginosa strains or even
from P. aeruginosa to enterobacteria [4], [5]. In addition,
KPC-producing carbapenem-resistant P. aeruginosa
strains have potential resistance to all betalactam anti-
biotics except Azthronam [5], [6]. This can cause complic-
ations in the treatment of infections related to KPC-pro-
ducing bacteria.
Our findings showed thatMHT had an excellent sensitivity
(100%) but low specificity (2.6%) for the detection of KPC
among Iranian bacterial specimens.We suggest thatMHT
can be used as a primary screening test, since only two
out of 75 MHT-positive strains were confirmed by PCR.
In Argentina, sensitivity and specificity of MHT for car-
bapenemase-producing P. aeruginosa were reported to
be 78% and 57%, respectively [14], [15]. However, the
use of inhibitor boronic acid led to a significant increase
of 97% in sensitivity and specificity [14]. Despite high
sensitivity, MHT can have variable specificity due to dif-
ferent incidences of carbapenemase in different geograph-
ical areas (57%–≥90%) [12], [14], [15]. For instance, in
Colombia in 2007, three KPC-producing P. aeruginosa
strains were identified [16], and in 2009, one KPC-pro-
ducing P. aeruginosa strains was isolated [17]. A study
conducted in the USA in 2009 reported one KPC-produc-
ing P. putida strain and one E. cloacae strain from one
patient, where MHT was positive for both [18]. Addition-
ally, in 2010, one KPC-producing P. aeruginosa strain
was isolated in the USA [2]. Despite global emergence of
KPC-producing strains of P. aeruginosa, it still uncommon
and is thought to be sporadic (yet its rapid detection is
necessary) [2], [16], [17], [18]. In our study, two KPC-
producing P. aeruginosa strains were identified, which is
the first report from Iran to the best of our knowledge.
On the other hand, the results of this study confirmed
that only one of three strains with positive result in com-
bination diskmethod (meropenem plus APBA) confirmed
by PCR as a KPC producer.
These findings indicate that the sensitivity and specificity
of inhibitory test (use of boronic acid) could not be ex-
plained by our results. This is despite the fact that false
positive results were eliminated using Oxacillin plus
Meropenem in our methodology. Thus, our findings may
suggest that MHT, despite its excellent sensitivity, has
variable specificity dependent of species of isolated
bacteria and also depending on different geographical
areas. Also, the use of a KPC inhibitor such as boronic
acid may not lead to a reasonably high sensitivity and
specificity among Iranian bacterial specimens. Therefore,
PCR should be considered as the gold standard for the
detection of KPC-producing P. aeruginosa for the time
being.
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